Discover Top 15 Companies in Blood Testing Market: Global Share, Market Size, Revenue Report (2024-2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Blood Testing Market Size is projected To Grow from USD 95.85 Billion in 2024 to USD 201.08 Billion by 2035, at a CAGR of 6.97% during the forecast period 2025–2035. The market is expected to grow as a result of increased awareness of preventative healthcare, technological advancements in testing, and rising healthcare spending by governments and regulatory agencies that actively support routine diagnostic testing to enhance patient outcomes.
Introduction
The Global Blood Testing Market Size refers to the industry devoted to creating, manufacturing, and distributing diagnostic tests that examine blood samples in order to identify illnesses, track medical conditions, and inform treatment choices is known as the global blood testing market. In order to detect infections, long-term illnesses, and genetic disorders, these tests measure elements such as cells, proteins, and chemicals. Furthermore, the intricacy and expense of certain sophisticated blood testing technologies, which can restrict their accessibility, especially in developing nations, are major factors impeding the market's growth. Strict regulatory requirements, like the FDA's approval process for new diagnostic devices, can also slow down the pace of advancement by delaying the market introduction of creative testing solutions. Additionally, some areas have restrictive reimbursement policies that limit patients' access to these technologies, particularly for non-invasive or home-based tests. The full cost of some blood tests may frequently be covered by insurance companies, especially for conditions that are still being researched or are not yet well known, which further impedes market expansion. The combination of these elements makes it difficult for new services and technologies to be widely adopted.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights - Download the Brochure now and dive deeper into the future of the Blood Testing Market.
Blood Testing Market Size & Statistics
- The Market Size for Blood Testing Was Estimated to be Worth USD 95.85 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 6.97% Between 2025 and 2035.
- The Global Blood Testing Market is Anticipated to Reach USD 201.08 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Blood Testing Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Blood Testing market.
- Germany Blood Testing Market Was Valued at USD 4.03 Billion in 2023 and is Projected to Reach USD 6.98 Billion by 2033, Growing Steadily at a CAGR of 5.65%.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the blood testing market. The scientific developments in the healthcare industry in nations like China, Japan, Israel, India, and a few others are the primary drivers of this region's expansion. The market's expansion has also been aided by the growing interest in blood testing methodology development and research from both the public and private sectors. Additionally, the market has grown as a result of growing government initiatives to develop the medical sectors in nations like Japan and India.
North America is expected to generate the highest demand during the forecast period in the blood testing market. The increasing prevalence of chronic diseases, improvements in diagnostic technologies, and growing healthcare awareness are some of the factors propelling the market growth in North America. Another important factor driving the market's expansion is technological developments in blood testing equipment and protocols. Innovations in molecular diagnostics, point-of-care testing, and continuous glucose monitoring (CGM) devices have completely changed the way diseases are identified and treated. Businesses that are at the forefront of introducing innovative solutions to the market include Roche with their COBAS systems and Abbott with their FreeStyle Libre glucose monitoring system.
Top 10 Recycled Plastics Trends
- Rise of Preventive Healthcare
- Technological Advancements
- Home-Based and Remote Testing
- Chronic Disease Monitoring
- Expansion in Emerging Markets
- Personalized Medicine
- Biomarker Discovery
- Regulatory Support and Funding
- Integration with Wearables and Digital Health
- Market Consolidation and Strategic Partnerships
1. Rise of Preventive Healthcare
The Global Blood Testing Market Size is being greatly impacted by the rise of preventive healthcare, as people and healthcare systems place a greater emphasis on early disease detection and proactive management. Regular blood tests are becoming an essential part of routine medical checkups as people become more aware of the advantages of detecting health problems before symptoms manifest. With the goal of lowering long-term treatment costs and enhancing patient outcomes, governments and healthcare providers are aggressively supporting these diagnostics through public health campaigns and policy initiatives.
2. Technological Advancements
By improving diagnostics' speed, accuracy, and accessibility, technological developments are transforming the global blood testing industry. Improvements in automation and AI-powered analysis are simplifying lab procedures and allowing for more accurate interpretation of intricate data. By shrinking testing platforms, lab-on-a-chip technologies enable quick results with small sample sizes. Additionally, the development of point-of-care and non-invasive testing tools is empowering physicians and patients with real-time information, eliminating the need for centralized lab visits, and enabling prompt medical decisions.
3. Home-Based and Remote Testing
As consumers look for healthcare solutions that are more convenient and accessible, home-based and remote blood testing is becoming more popular. With the increasing number of easy-to-use home testing kits available, people can obtain results and collect samples without going to a clinic, increasing the flexibility and efficiency of diagnostics. The integration of telehealth services, which allow for remote consultations and ongoing health condition monitoring, further accelerates this trend. When taken as a whole, these developments are revolutionizing the diagnostic paradigm, giving patients greater control over their health care, and increasing access to care for underserved and rural populations.
4. Chronic Disease Monitoring
As a vital tool for continuous monitoring and management, blood testing is in high demand due to the growing global burden of chronic diseases like diabetes, heart disease, and cancer. For monitoring the course of the disease, assessing the efficacy of treatment, and averting complications, tests such as tumor markers, lipid panels, and glucose levels are crucial. Regular blood tests have become essential to individualized treatment plans and preventative health initiatives because these conditions frequently necessitate lifelong care. Healthcare systems are being compelled by this increasing demand to make investments in blood testing technologies that are more effective, precise, and easily accessible in order to support the treatment of chronic illnesses.
5. Expansion in Emerging Markets
The blood testing industry is growing quickly in emerging markets like Asia-Pacific and Latin America thanks to advancements in healthcare infrastructure and growing disposable incomes. More people can now afford and seek out routine blood tests as a result of public and private investments in updating healthcare facilities and increasing access to diagnostic services. Demand is also being accelerated by rising awareness of preventive healthcare and the rise in lifestyle-related diseases.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the recycled plastics market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 16 Companies Leading the Blood Testing Market
- Abbott Laboratories
- Roche Diagnostics
- Bio-Rad Laboratories
- Quest Diagnostics
- Danaher Corporation
- Becton Dickinson & Company
- Thermo Fisher Scientific
- bioMérieux S.A.
- Siemens Healthineers
- Trinity Biotech PLC
- Novartis AG
- PerkinElmer
- Waters Corporation
- Shimadzu Corporation
- Una Health
- Biomerica, Inc.
- Others
1. Abbott Laboratories
Headquarters – Illinois, United States
Abbott Laboratories (Abbott) is a health care and medical device company that develops, creates, produces, and markets goods. Products related to gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system, respiratory drugs and vaccines, biosimilars, core laboratory and transfusion medicine systems, point-of-care systems, rapid diagnostics lateral flow testing, informatics and automation solutions, nutritional products, rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products, and neuromodulation products are among its primary offerings.
2. Roche Diagnostics
Headquarters – Basel, Switzerland
A division of F. Hoffmann-La Roche Ltd., Roche Diagnostics International Ltd. (Roche Diagnostics) supplies diagnostic system solutions to medical facilities, labs, and physician offices. The company creates, manufactures, and maintains software and instrument systems for use in bioanalytical and in-vitro diagnostic research. In addition, it provides molecular diagnostic reagents, test systems, workflow solutions, and diagnostic analysis systems. Blood glucose meters and point-of-care testing equipment are two of its main offerings.
3. Bio-Rad Laboratories
Headquarters – Hercules, California, the US.
The company Bio-Rad Laboratories Inc. (Bio-Rad) creates, produces, and sells tools, software, consumables, and reagents for the clinical diagnostics and life science research markets. Digital PCR, blood type and antibody detection systems, antibodies, autoimmune testing kits, and tools for cell isolation and analysis are some of its products. Among other fields, bioprocess analytics, cell research, gene expression analysis, immunology, and mutation detection use the company's products. University and research institutions, hospitals, commercial and public health laboratories, diagnostic manufacturers, and businesses in the food, chemical, pharmaceutical, and biotechnology sectors are among its clients. Through distributors, agents, brokers, resellers, and direct sales channels, Bio-Rad sells its goods.
4. Quest Diagnostics
Headquarters – Plaza Drive, Secaucus, New Jersey 07094, United States.
As a top supplier of diagnostic information services, Quest Diagnostics assists patients and medical professionals in making more informed choices. Regular blood work, sophisticated genetic testing, and wellness screenings are just a few of the many services the company provides. Focusing on innovation and data-driven healthcare, Quest supports early disease detection, preventive care, and individualized treatment plans by utilizing state-of-the-art technologies and a wealth of clinical knowledge. Testing is easily accessible thanks to its network of labs and patient service centers, and its collaborations with employers, insurers, and hospitals strengthen its influence on how healthcare is delivered today.
5. Danaher Corporation
Headquarters – Pennsylvania Avenue NW, Suite 800W, Washington, D.C. 20037, United States.
A leader in science and technology worldwide, Danaher Corporation creates, produces, and sells cutting-edge goods and services for a wide range of industries. Life sciences, diagnostics, biotechnology, and environmental solutions are some of the important industries in which it operates. Danaher, which is well-known for its stringent operating philosophy and emphasis on ongoing development, propels developments in industrial applications, research, and healthcare.
Are you ready to discover more about the blood testing market?
The report provides an in-depth analysis of the leading companies operating in the global blood testing market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Abbott Laboratories
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Roche Diagnostics
- Bio-Rad Laboratories
- Quest Diagnostics
- Danaher Corporation
- Becton Dickinson & Company
- Thermo Fisher Scientific
- bioMérieux S.A.
- Siemens Healthineers
- Trinity Biotech PLC
Conclusion
The Market for Blood Tests is about to undergo a major shift due to growing awareness of preventive healthcare, technological advancements, and easier access in developing nations. The need for quicker, more precise, and more patient-friendly diagnostics is only going to increase, despite obstacles like reimbursement restrictions and regulatory barriers. Major players are spending money on cutting-edge solutions like tools for tracking chronic diseases, AI-powered platforms, and home-based testing. Asia Pacific exhibits the fastest growth potential, while North America leads in demand. The competitive landscape is being shaped by strategic alliances and market consolidation, which have established blood testing as a vital component of contemporary healthcare.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?